pentobarbital will reduce the extent or impact of aripiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.Contraindicated (1)pentobarbital will decrease the level or outcome of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Prevent coadministration. Robust or reasonable CY